Fecal microbiota transplant – a new frontier in inflammatory bowel disease

Código QR

Fecal microbiota transplant – a new frontier in inflammatory bowel disease

Tagore Sunkara,1 Prashanth Rawla,2 Andrew Ofosu,1 Vinaya Gaduputi3 1Division of Gastroenterology and Hepatology, The Brooklyn Hospital Center, Mount Sinai Health System, New York, NY, USA; 2Department of Internal Medicine, Sovah Health, Martinsville, VA, USA; 3Division of Gastroenterology, SBH Healt...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sunkara T, Rawla P, Ofosu A, Gaduputi V
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	Fecal Microbiota Transplant FMT Inflammatory bowel disease IBD microbiome dysbiosis Pathology RB1-214 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/dd1fb66cce054d6bba96c62a529e2c04
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease
por: Azimirad M, et al.
Publicado: (2020)

Improvement in Clinical Symptoms and Fecal Microbiome After Fecal Microbiota Transplantation in a Dog with Inflammatory Bowel Disease
por: Niina A, et al.
Publicado: (2019)

Commentary on key aspects of fecal microbiota transplantation in small animal practice
por: Chaitman J, et al.
Publicado: (2016)

Dynamic Colonization of Microbes and Their Functions after Fecal Microbiota Transplantation for Inflammatory Bowel Disease
por: Nathaniel D. Chu, et al.
Publicado: (2021)

Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent <named-content content-type="genus-species">Clostridioides difficile</named-content> Infection
por: Danielle Barrios Steed, et al.
Publicado: (2020)

Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center
por: Gianluca Ianiro, et al.
Publicado: (2021)

Effect of fecal microbiota transplantation in patients with slow transit constipation and the relative mechanisms based on the protein digestion and absorption pathway
por: Lulu Xie, et al.
Publicado: (2021)

Distinct Fecal and Plasma Metabolites in Children with Autism Spectrum Disorders and Their Modulation after Microbiota Transfer Therapy
por: Dae-Wook Kang, et al.
Publicado: (2020)

Fecal Microbiome Transplantation from Children with Autism Spectrum Disorder Modulates Tryptophan and Serotonergic Synapse Metabolism and Induces Altered Behaviors in Germ-Free Mice
por: Lu Xiao, et al.
Publicado: (2021)

The microbiota in inflammatory bowel disease: current and therapeutic insights
por: Lane ER, et al.
Publicado: (2017)

Impact of Amoxicillin-Clavulanate followed by Autologous Fecal Microbiota Transplantation on Fecal Microbiome Structure and Metabolic Potential
por: Christopher Bulow, et al.
Publicado: (2018)

Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
por: Cao Y, et al.
Publicado: (2021)

Experiencia del trasplante de microbiota fecal a través de colonoscopía en el tratamiento de la infección por Clostridium difficile recurrente
por: Quera,Rodrigo, et al.
Publicado: (2018)

Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat <named-content content-type="genus-species">Clostridium difficile</named-content> Infection
por: Christopher Staley, et al.
Publicado: (2019)

Separation of Donor and Recipient Microbial Diversity Allows Determination of Taxonomic and Functional Features of Gut Microbiota Restructuring following Fecal Transplantation
por: Evgenii I. Olekhnovich, et al.
Publicado: (2021)

Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in <named-content content-type="genus-species">Clostridioides difficile</named-content> Infection
por: Craig Haifer, et al.
Publicado: (2021)

Epidemiology of Inflammatory Bowel Diseases (IBD) in Iran: A Review of 740 Patients in Fars Province, Southern Iran
por: Seyed Alireza Taghavi, et al.
Publicado: (2013)

Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
por: Ning Li, et al.
Publicado: (2021)

Corrigendum: Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
por: Ning Li, et al.
Publicado: (2021)

Physical Activity Shapes the Intestinal Microbiome and Immunity of Healthy Mice but Has No Protective Effects against Colitis in MUC2<sup>−/−</sup> Mice
por: Mehrbod Estaki, et al.
Publicado: (2020)

Gut and Cutaneous Microbiome Featuring Abundance of Lactobacillus reuteri Protected Against Psoriasis-Like Inflammation in Mice
por: Chen HL, et al.
Publicado: (2021)

Successful Experience of Fecal Transplantation in a Patient with Severe Pseudomembranous Colitis
por: L. R. Shedoeva, et al.
Publicado: (2021)

Enhancement of Circulating and Intestinal T Regulatory Cells and Their Expression of Helios and Neuropilin-1 in Children with Inflammatory Bowel Disease
por: Sznurkowska K, et al.
Publicado: (2020)

Gut Microbiota Contributes to Host Defense Against Klebsiella pneumoniae-Induced Liver Abscess
por: Zheng Y, et al.
Publicado: (2021)

Fecal Microbiota Transplantation in Gestating Sows and Neonatal Offspring Alters Lifetime Intestinal Microbiota and Growth in Offspring
por: Ursula M. McCormack, et al.
Publicado: (2018)

Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species
por: Kai Nie, et al.
Publicado: (2021)

Fecal Microbiota Transplantation Beneficially Regulates Intestinal Mucosal Autophagy and Alleviates Gut Barrier Injury
por: Saisai Cheng, et al.
Publicado: (2018)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Xiufang Cui, et al.
Publicado: (2021)

Iron Deficiency Anemia in Inflammatory Bowel Diseases—A Narrative Review
por: Dagmara Mahadea, et al.
Publicado: (2021)

The Immunomodulatory Functions of Butyrate
por: Siddiqui MT, et al.
Publicado: (2021)

Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn’s Disease Patients
por: Matthew K. Doherty, et al.
Publicado: (2018)

mSphere of Influence: Microbiome-Associated Phenotypes Are Modifiable
por: Michael H. Woodworth
Publicado: (2020)

Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management – a follow-up study in a private inflammatory bowel disease center (2003–2017)
por: Cury DB, et al.
Publicado: (2019)

Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives
por: Rawla P, et al.
Publicado: (2018)

Roles of Gut Bacteriophages in the Pathogenesis and Treatment of Inflammatory Bowel Disease
por: Lingling Qv, et al.
Publicado: (2021)

Reconstruction of intestinal microecology of Type 2 diabetes by fecal microbiota transplantation: Why and how
por: Kaijian Hou, et al.
Publicado: (2021)

Management of fecal incontinence - focus on a vaginal insert for bowel control
por: Sokol ER
Publicado: (2016)

Trasplante de microbiota fecal en infección recurrente por Clostridium difficile: Experiencia local a partir de un caso clínico
por: Moscoso,Felipe, et al.
Publicado: (2015)

Effects of fecal microbiota transplant on DNA methylation in subjects with metabolic syndrome
por: Eduard W. J. van der Vossen, et al.
Publicado: (2021)

The role of inflammation in irritable bowel syndrome (IBS)
por: Ng QX, et al.
Publicado: (2018)